Increased Intracranial Arterial Pulsatility and Microvascular Brain Damage in Pseudoxanthoma Elasticum

References

1. 1.↵
   1. Plomp AS,
   2. Toonstra J,
   3. Bergen AA, et al

   . Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings. Am J Med Genet A 2010;152A:1049–58 doi:10.1002/ajmg.a.33329 pmid:20358627

   CrossRefPubMed
2. 2.↵
   1. Kranenburg G,
   2. de Jong PA,
   3. Mali WP, et al

   . Prevalence and severity of arterial calcifications in pseudoxanthoma elasticum (PXE) compared to hospital controls: novel insights into the vascular phenotype of PXE. Atherosclerosis 2017;256:7–14 doi:10.1016/j.atherosclerosis.2016.11.012 pmid:27940376

   CrossRefPubMed
3. 3.↵
   1. Risseeuw S,
   2. Ossewaarde-van Norel J,
   3. van Buchem C, et al

   . The extent of angioid streaks correlates with macular degeneration in pseudoxanthoma elasticum. Am J Ophthalmol 2020;220:82–90 doi:10.1016/j.ajo.2020.07.022 pmid:32702361

   CrossRefPubMed
4. 4.↵
   1. Leftheriotis G,
   2. Kauffenstein G,
   3. Hamel JF, et al

   . The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum. PLoS One 2014;9:e96003 doi:10.1371/journal.pone.0096003 pmid:24800819

   CrossRefPubMed
5. 5.↵
   1. Kauw F,
   2. Kranenburg G,
   3. Kappelle LJ, et al

   . Cerebral disease in a nationwide Dutch pseudoxanthoma elasticum cohort with a systematic review of the literature. J Neurol Sci 2017;373:167–72 doi:10.1016/j.jns.2016.12.053 pmid:28131180

   CrossRefPubMed
6. 6.↵
   1. Cerrato P,
   2. Giraudo M,
   3. Baima C, et al

   . Asymptomatic white matter ischemic lesions in a patient with pseudoxanthoma elasticum. J Neurol 2005;252:848–49 doi:10.1007/s00415-005-0757-4 pmid:15765271

   CrossRefPubMed
7. 7.↵
   1. Pavlovic AM,
   2. Zidverc-Trajkovic J,
   3. Milovic MM, et al

   . Cerebral small vessel disease in pseudoxanthoma elasticum: three cases. Can J Neurol Sci 2005;32:115–18 doi:10.1017/s0317167100016991 pmid:15825558

   CrossRefPubMed
8. 8.↵
   1. Manini A,
   2. Pantoni L,
   3. Pantoni L, et al

   . Genetic causes of cerebral small vessel diseases: a practical guide for neurologists. Neurology 2022;100:766–83 doi:10.1212/WNL.0000000000201720 pmid:36535782

   CrossRefPubMed
9. 9.↵
   1. Omarjee L,
   2. Fortrat JO,
   3. Larralde A, et al

   . Internal carotid artery hypoplasia: a new clinical feature in pseudoxanthoma elasticum. J Stroke 2019;21:108–11 doi:10.5853/jos.2018.02705 pmid:30732446

   CrossRefPubMed
10. 10.↵
    1. Mention PJ,
    2. Lacoeuille F,
    3. Leftheriotis G, et al

    . 18F-flurodeoxyglucose and 18F-sodium fluoride positron emission tomography/computed tomography imaging of arterial and cutaneous alterations in pseudoxanthoma elasticum. Circ Cardiovasc Imaging 2018;11:e007060 doi:10.1161/CIRCIMAGING.117.007060 pmid:29321214

    FREE Full Text
11. 11.↵
    1. Bartstra JW,
    2. Spiering W,
    3. van den Ouweland JM, et al

    . Increased elastin degradation in pseudoxanthoma elasticum is associated with peripheral arterial disease independent of calcification. J Clin Med 2020;9:2771–11 doi:10.3390/jcm9092771 pmid:32859086

    CrossRefPubMed
12. 12.↵
    1. van Tuijl RJ,
    2. Ruigrok YM,
    3. Velthuis BK, et al

    . Velocity pulsatility and arterial distensibility along the internal carotid artery. J Am Heart Assoc 2020;9:e016883 doi:10.1161/JAHA.120.016883 pmid:32783485

    CrossRefPubMed
13. 13.↵
    1. Bartstra JW,
    2. van Tuijl RJ,
    3. de Jong PA, et al

    . Pulsatility attenuation along the carotid siphon in pseudoxanthoma elasticum. AJNR Am J Neuroradiol 2021;42:2030–33 doi:10.3174/ajnr.A7288 pmid:34561212

    Abstract/FREE Full Text
14. 14.↵
    1. van Tuijl RJ,
    2. Ruigrok YM,
    3. Geurts LJ, et al

    . Does the internal carotid artery attenuate blood-flow pulsatility in small vessel disease? A 7 T 4D-flow MRI study. J Magn Reson Imaging 2022;56:527–35 doi:10.1002/jmri.28062 pmid:34997655

    CrossRefPubMed
15. 15.↵
    1. Panh L,
    2. Lairez O,
    3. Ruidavets JB, et al

    . Coronary artery calcification: from crystal to plaque rupture. Arch Cardiovasc Dis 2017;110:550–61 doi:10.1016/j.acvd.2017.04.003 pmid:28735837

    CrossRefPubMed
16. 16.↵
    1. Lanzer P,
    2. Boehm M,
    3. Sorribas V, et al

    . Medial vascular calcification revisited: review and perspectives. Eur Heart J 2014;35:1515–25 doi:10.1093/eurheartj/ehu163 pmid:24740885

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Chirinos JA,
    2. Segers P,
    3. Hughes T, et al

    . Large-artery stiffness in health and disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;74:1237–63 doi:10.1016/j.jacc.2019.07.012 pmid:31466622

    FREE Full Text
18. 18.↵
    1. Mitchell GF

    . Aortic stiffness, pressure and flow pulsatility, and target organ damage. J Appl Physiol (1985) 2018;125:1871–80 doi:10.1152/japplphysiol.00108.2018 pmid:30359540

    CrossRefPubMed
19. 19.↵
    1. Vos A,
    2. Kranenburg G,
    3. de Jong PA, et al

    . The amount of calcifications in pseudoxanthoma elasticum patients is underestimated in computed tomographic imaging; a post-mortem correlation of histological and computed tomographic findings in two cases. Insights Imaging 2018;9:493–98 doi:10.1007/s13244-018-0621-6 pmid:29858817

    CrossRefPubMed
20. 20.↵
    1. Hoffmann U,
    2. Kwait DC,
    3. Handwerker J, et al

    . Vascular calcification in ex vivo carotid specimens: precision and accuracy of measurements with multi-detector row CT. Radiology 2003;229:375–81 doi:10.1148/radiol.2292021016 pmid:14526093

    CrossRefPubMed
21. 21.↵
    1. Correia de Verdier M,
    2. Wikstrom J

    . Normal ranges and test-retest reproducibility of flow and velocity parameters in intracranial arteries measured with phase-contrast magnetic resonance imaging. Neuroradiology 2016;58:521–31 doi:10.1007/s00234-016-1661-6 pmid:26882908

    CrossRefPubMed
22. 22.↵
    1. Buijs PC,
    2. Krabbe-Hartkamp MJ,
    3. Bakker CJ, et al

    . Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology 1998;209:667–74 doi:10.1148/radiology.209.3.9844657 pmid:9844657

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Wardlaw JM,
    2. Smith EE,
    3. Biessels GJ, et al

    ; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38 doi:10.1016/S1474-4422(13)70124-8 pmid:23867200

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Bartstra JW,
    2. van den Beukel TC,
    3. Van Hecke W, et al

    . Intracranial arterial calcification: prevalence, risk factors, and consequences: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:1595–604 doi:10.1016/j.jacc.2020.07.056 pmid:32972537

    FREE Full Text
25. 25.↵
    1. Wu X,
    2. Wang L,
    3. Zhong J, et al

    . Impact of intracranial artery calcification on cerebral hemodynamic changes. Neuroradiology 2018;60:357–63 doi:10.1007/s00234-018-1988-2 pmid:29426978

    CrossRefPubMed
26. 26.↵
    1. Park KY,
    2. Chung PW,
    3. Kim YB, et al

    . Increased pulsatility index is associated with intracranial arterial calcification. Eur Neurol 2013;69:83–88 doi:10.1159/000342889 pmid:23154455

    CrossRefPubMed
27. 27.↵
    1. Bos D,
    2. Vernooij MW,
    3. Elias-Smale SE, et al

    . Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement 2012;8:S104–111 doi:10.1016/j.jalz.2012.01.008 pmid:22537801

    CrossRefPubMed
28. 28.↵
    1. Hong NR,
    2. Seo HS,
    3. Lee YH, et al

    . The correlation between carotid siphon calcification and lacunar infarction. Neuroradiology 2011;53:643–49 doi:10.1007/s00234-010-0798-y pmid:21088962

    CrossRefPubMed
29. 29.↵
    1. Bos D,
    2. Vernooij MW,
    3. de Bruijn RF, et al

    . Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline. Alzheimers Dement 2015;11:639–47.e1 doi:10.1016/j.jalz.2014.05.1758 pmid:25150731

    CrossRefPubMed
30. 30.↵
    1. Berman SE,
    2. Rivera-Rivera LA,
    3. Clark LR, et al

    . Intracranial arterial 4D-flow is associated with metrics of brain health and Alzheimer’s disease. Alzheimers Dement (Amst) 2015;1:420–28 doi:10.1016/j.dadm.2015.09.005 pmid:26693176

    CrossRefPubMed
31. 31.↵
    1. Wahlin A,
    2. Ambarki K,
    3. Birgander R, et al

    . Intracranial pulsatility is associated with regional brain volume in elderly individuals. Neurobiol Aging 2014;35:365–72 doi:10.1016/j.neurobiolaging.2013.08.026 pmid:24080175

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Birnefeld J,
    2. Wahlin A,
    3. Eklund A, et al

    . Cerebral arterial pulsatility is associated with features of small vessel disease in patients with acute stroke and TIA: a 4D flow MRI study. J Neurol 2020;267:721–30 doi:10.1007/s00415-019-09620-6 pmid:31728712

    CrossRefPubMed
33. 33.↵
    1. Kockelkoren R,
    2. Vos A,
    3. Hecke WV, et al

    . Computed tomographic distinction of intimal and medial calcification in the intracranial internal carotid artery. PLoS One 2017;12:e0168360–11 doi:10.1371/journal.pone.0168360

    CrossRef
34. 34.↵
    1. Van Den Beukel TC,
    2. Van Der Toorn JE,
    3. Vernooij MW, et al

    . Morphological subtypes of intracranial internal carotid artery arteriosclerosis and the risk of stroke. Stroke 2022;53:1339–47 doi:10.1161/STROKEAHA.121.036213 pmid:34802249

    CrossRefPubMed
35. 35.↵
    1. Melgarejo JD,
    2. Vernooij MW,
    3. Ikram MA, et al

    . Intracranial carotid arteriosclerosis mediates the association between blood pressure and cerebral small vessel disease. Hypertension 2023;80:618–28 doi:10.1161/HYPERTENSIONAHA.122.20434 pmid:36458543

    CrossRefPubMed
36. 36.↵
    1. Tsao CW,
    2. Pencina KM,
    3. Massaro JM, et al

    . Cross-sectional relations of arterial stiffness, pressure pulsatility, wave reflection, and arterial calcification. Arterioscler Thromb Vasc Biol 2014;34:2495–500 doi:10.1161/ATVBAHA.114.303916 pmid:25169933

    Abstract/FREE Full Text
37. 37.↵
    1. Jansen RS,
    2. Duijst S,
    3. Mahakena S, et al

    . ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation: brief report. Arterioscler Thromb Vasc Biol 2014;34:1985–89 doi:10.1161/ATVBAHA.114.304017 pmid:24969777

    Abstract/FREE Full Text
38. 38.↵
    1. Dedinszki D,
    2. Szeri F,
    3. Kozak E, et al

    . Oral administration of pyrophosphate inhibits connective tissue calcification. EMBO Mol Med 2017;9:1463–70 doi:10.15252/emmm.201707532 pmid:28701330

    Abstract/FREE Full Text
39. 39.↵
    1. Ziegler SG,
    2. Ferreira CR,
    3. MacFarlane EG, et al

    . Ectopic calcification in pseudoxanthoma elasticum responds to inhibition of tissue-nonspecific alkaline phosphatase. Sci Transl Med 2017;9:eaal1669 doi:10.1126/scitranslmed.aal1669 pmid:28592560

    Abstract/FREE Full Text
40. 40.↵
    1. Bartstra JW,
    2. de Jong PA,
    3. Kranenburg G, et al

    . Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum. Atherosclerosis 2020;292:37–41 doi:10.1016/j.atherosclerosis.2019.10.004 pmid:31756632

    CrossRefPubMed
41. 41.↵
    1. Kranenburg G,
    2. de Jong PA,
    3. Bartstra JW, et al

    . Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum. J Am Coll Cardiol 2018;71:1117–26 doi:10.1016/j.jacc.2017.12.062 pmid:29519353

    FREE Full Text
42. 42.↵
    1. Vernooij MW,
    2. Ikram MA,
    3. Tanghe HL, et al

    . Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821–28 doi:10.1056/NEJMoa070972 pmid:17978290

    CrossRefPubMedWeb of Science